pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 43 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07418138: Effect of Pre-Transplant Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma Patients With Liver Transplantation

Sponsor: Hu Liangshuo. Phase: . Conditions: Liver Transplantation, Hepatocellular Carcinoma (HCC), Tyrosine Kinase Inhibitor, Survival Rate

full page →ctgov ↗
›RECRUITINGphase readoutNCT07362238: Daratumumab Versus Rituximab in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)Institute of Hematology & Blood Diseases Hospital

Sponsor: Institute of Hematology & Blood Diseases Hospital, China. Phase: PHASE2. Conditions: Immune Thrombocytopenia, Treatment

full page →ctgov ↗
›TERMINATEDphase readoutNCT04221438: Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node InvolvementArray BioPharma Inc

Sponsor: ECOG-ACRIN Cancer Research Group. Phase: PHASE2. Conditions: Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in Lymph Node, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Recurrent Cutaneous Melanoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT04461158: CCCR Lupus Patient Navigator Program

Sponsor: Medical University of South Carolina. Phase: NA. Conditions: Systemic Lupus Erythematosus (SLE)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07307248: To Evaluate Early (2-Week) vs. Standard (4-Week) Metal Stent Removal Following Endoscopic Ultrasound Guided WON Drainage

Sponsor: Asian Institute of Gastroenterology, India. Phase: NA. Conditions: Walled Off Necrosis

full page →ctgov ↗
›COMPLETEDphase readoutNCT06877026: FibroScan-Reproducibility and Repeatability Study

Sponsor: Echosens. Phase: NA. Conditions: Non-Alcoholic Fatty Liver Disease, Liver Disease; Alcohol-Related

full page →ctgov ↗
›RECRUITINGphase readoutNCT07418385: Voluntary HIV Screening in the General Population in France

Sponsor: Université de Reims Champagne-Ardenne. Phase: . Conditions: Human Immunodeficiency Virus (HIV)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03078543: Ten Year Implant Survivorship of the ANTHEM™ PS Total Knee SystemSMITH & NEPHEW PLC

Sponsor: Smith & Nephew, Inc.. Phase: . Conditions: Arthroplasty, Replacement, Knee

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07480343: 5-Year Postoperative Outcomes of Patients Who Completed the CREST Study

Sponsor: Iantrek, Inc.. Phase: . Conditions: Open-angle Glaucoma (OAG)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07550543: PEMF Therapy in Shoulder Tendinopathy

Sponsor: Balnear and Rehabilitation Sanatorium Techirghiol. Phase: NA. Conditions: Shoulder Tendinopathy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07298408: Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot StudyJazz Pharmaceuticals plc

Sponsor: Florida A&M University. Phase: PHASE1. Conditions: Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07422025: Prognostic Value of Preoperative Frailty Assessment in Geriatric Lower Limb Orthopedic Surgery

Sponsor: Benha University. Phase: . Conditions: Lower Limb Fracture

full page →ctgov ↗
›RECRUITINGphase readoutNCT07414576: AI-driven Total Parenteral Nutrition Platform

Sponsor: Takeoff41, Inc.. Phase: NA. Conditions: Intestinal Failure

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05003817: Controlled Trial of High-risk Coronary Intervention With Percutaneous Left Ventricular UnloadingGuy's and St Thomas' NHS Foundation Trust

Sponsor: Guy's and St Thomas' NHS Foundation Trust. Phase: PHASE3. Conditions: Ischemic Heart Disease, Coronary Artery Disease

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07450040: Efficacy and Safety of Tislelizumab Combined With Gemcitabine and Peraspartase in the Treatment of Patients With Primary Stage I-II NK/T Cell LymphomaContinuity Biosciences LLC

Sponsor: Eye & ENT Hospital of Fudan University. Phase: . Conditions: ORR, OS, PFS

full page →ctgov ↗
›RECRUITINGphase readoutNCT02280889: Quality of Life and Stigmatization in Children With Congenital Melanocytic Nevi Before and After Nevus Excision

Sponsor: University Children's Hospital, Zurich. Phase: . Conditions: Quality of Life, Stigmatization

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07463768: Study Evaluating the Efficacy and Safety of the Addition of Ivosidenib to Oral Azacitidine (Onureg®) in Patients Over 55 With Acute Myeloid Leukemia (AML) and IDH1 Mutation, in Complete Remission After Intensive Chemotherapy.Bristol-Myers Squibb Co

Sponsor: French Innovative Leukemia Organisation. Phase: PHASE2. Conditions: Acute Myeloid Leukemia

full page →ctgov ↗
›RECRUITINGphase readoutNCT06777368: REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE

Sponsor: Medtronic Cardiovascular. Phase: . Conditions: Aortic Stenosis

full page →ctgov ↗
›RECRUITINGphase readoutNCT05316571: Sitting Interruption and Whole-body Cardiovascular Health

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Sedentary Behavior, Sedentary Time

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05537064: Centralized Prescribing for StatinsUniversity of Pennsylvania

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Hyperlipidemias

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524764: Female Reproductive Health in Canadian Armed Forces

Sponsor: Université de Sherbrooke. Phase: . Conditions: Pregnancy, Pelvic Floor Dysfunction, Military Personnel, Contraception, Infertility, Women's Health

full page →ctgov ↗
›COMPLETEDphase readoutNCT04602598: Zanubrutinib in Patients With IgG4-Related DiseaseBeOne Medicines Ltd.

Sponsor: Matthew C. Baker. Phase: PHASE2. Conditions: IgG4 Related Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT05470998: L-Arginine in Children Having Sickle Cell Disease With Increased Tricuspid Regurgitant Jet Velocity

Sponsor: Tanta University. Phase: PHASE3. Conditions: Sickle Cell Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT06778863: A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationC4 Therapeutics, Inc.

Sponsor: Clasp Therapeutics, Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumor, Unresectable Solid Tumor, Metastatic Solid Tumor, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma, Lung Cancer, Ovarian Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma, Prostate Cancer, Bladder Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05289687: Daratumumab for Chemotherapy-Refractory Minimal Residual Disease in T Cell ALLJOHNSON & JOHNSON

Sponsor: Eastern Cooperative Oncology Group. Phase: PHASE2. Conditions: T-cell Acute Lymphoblastic Leukemia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07416487: Comparison of Outcome of Foley Catheter Versus Misoprostol for Induction of LaborAFYX Therapeutics A/S

Sponsor: Muhammad Aamir Latif. Phase: NA. Conditions: Labor

full page →ctgov ↗
›COMPLETEDphase readoutNCT05064293: Assisted Identification and Navigation of Early Mental Health Symptoms in Children

Sponsor: Kaiser Permanente. Phase: NA. Conditions: Adolescent Behavior, Mental Health Issue

full page →ctgov ↗
›RECRUITINGphase readoutNCT06896916: Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaAbbVie Inc.

Sponsor: AbbVie. Phase: PHASE1. Conditions: Multiple Myeloma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06472284: TetraGraph in Rocuronium Infusions

Sponsor: Joseph D. Tobias. Phase: NA. Conditions: Surgery

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04849884: To Evaluate the Performance of the CORI™ KNEE TENSIONER as an Accessory to the CORI™ Surgical System.SMITH & NEPHEW PLC

Sponsor: Smith & Nephew, Inc.. Phase: NA. Conditions: Arthroplasty, Replacement, Knee

full page →ctgov ↗
›RECRUITINGphase readoutNCT07544784: AK104 Plus Radiotherapy Combined With Standard Therapy Versus Standard Therapy as First-Line Treatment for pMMR/MSS CRLM (APSOC)

Sponsor: Fudan University. Phase: PHASE2. Conditions: Colorectal Cancer Liver Metastases (CRLM)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07197684: Ultrasound Guided Pecs Block and Ketamine Infusion for Preventing Chronic Pain in Patients Undergoing Breast Cancer SurgeryNRX Pharmaceuticals, Inc.

Sponsor: Aga Khan University. Phase: NA. Conditions: Breast Cancer, Pain, Chronic, Post Surgical Pain

full page →ctgov ↗
›COMPLETEDphase readoutNCT05773833: Indigenous Supported Agriculture "Go Healthy"Metallomix Inc

Sponsor: Oklahoma State University Center for Health Sciences. Phase: NA. Conditions: Diet, Healthy, Blood Pressure, Overweight or Obesity, Food Insecurity, Health Status

full page →ctgov ↗
›COMPLETEDphase readoutNCT02828852: Study of the Platelet Function During the Last Month of Pregnancy

Sponsor: University Hospital, Toulouse. Phase: NA. Conditions: Pregnancy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07512947: Study of YKST02 Alone or in Combination With YK012 in Patients With Active or Refractory Systemic Lupus Erythematosus

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE1. Conditions: System Lupus Erythematosus(SLE)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07501949: H-Wave® Device Stimulation for Post-operative Rotator Cuff Repair Surgery

Sponsor: Electronic Waveform Lab. Phase: NA. Conditions: Rotator Cuff Tear Surgical Repair

full page →ctgov ↗
›COMPLETEDphase readoutNCT03252249: Duration of Dual Anti-Platelet Therapy (DUAL-ACS)

Sponsor: University of Edinburgh. Phase: PHASE4. Conditions: Acute Coronary Syndrome, Coronary Artery Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT04533958: Evaluation of Hypnosis in Virtual Reality on the Anxiety of Patients With Metastatic Prostate Cancer Over Chemotherapy

Sponsor: Saint-Gregoire Private Hospital Center. Phase: NA. Conditions: Metastatic Prostate Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07378358: Evaluation of AI Large Models for Diagnosis and Treatment in Real-World Cases: Multicenter Retrospective Study

Sponsor: First Affiliated Hospital of Fujian Medical University. Phase: . Conditions: Urologic Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07320378: Clinical Study on the Safety and Efficacy of Tendon Stem Progenitor Cells Therapy for Rotator Cuff Tears

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University. Phase: EARLY_PHASE1. Conditions: Rotator Cuff Tendinopathy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321626: Romiplostim N01 for Platelet Recovery After Haploidentical HSCTAMGEN INC

Sponsor: First Affiliated Hospital of Zhejiang University. Phase: PHASE1. Conditions: Acute Myeloid Leukemia, MDS (Myelodysplastic Syndrome), Delayed Platelet Engraftment, HSCT

full page →ctgov ↗
›RECRUITINGphase readoutNCT07257185: MHB018A Treatment in Patients With Chronic Thyroid Eye DiseaseMinghui Pharmaceutical (Shanghai) Co Ltd

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd. Phase: PHASE3. Conditions: Thyroid Eye Disease (TED)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07154043: Comparison of IPC Therapy as an Alternative or an Adjunct to MLD Within CDT for BCRL

Sponsor: Pamukkale University. Phase: NA. Conditions: Breast Cancer-Related Lymphedema, BCRL

full page →ctgov ↗
›RECRUITINGphase readoutNCT05189925: NADPH Oxidase Correction in mRNA-transfected Granulocyte-enriched Cells in Chronic Granulomatous Disease (CGD)

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: PHASE1. Conditions: Chronic Granulomatous Disease, Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT05608525: Upper Limb tDCS in Chronic Stroke Patients (NOURISH)

Sponsor: National University Hospital, Singapore. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06860425: Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and Activity

Sponsor: Montefiore Medical Center. Phase: NA. Conditions: Mobile Applications, Cancer Patients

full page →ctgov ↗
›COMPLETEDphase readoutNCT05344443: Lemborexant Shift Work Treatment StudyUniversity of California San Francisco

Sponsor: University of California, San Francisco. Phase: PHASE4. Conditions: Shift-Work Related Sleep Disturbance

full page →ctgov ↗
›COMPLETEDphase readoutNCT04238715: A Study of E7090 in Participants With Unresectable Advanced or Metastatic Cholangiocarcinoma With Fibroblast Growth Factor Receptor (FGFR) 2 Gene FusionEisai Co Ltd

Sponsor: Eisai Co., Ltd.. Phase: PHASE2. Conditions: Cholangiocarcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07500571: The Correlation Between Neck Posture and Scapular Posture & the Effect Stabilization Exercises for the Scapula

Sponsor: Hallym University Dongtan Sacred Heart Hospital. Phase: NA. Conditions: Scapular Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT07392944: Multicomponent Exercise Program on Physical Function, Cognition and Falls Risk Among Older Adults Living in Nursing Homes (MOVE4CARE)

Sponsor: Universidade do Porto. Phase: NA. Conditions: Frailty, Dementia

full page →ctgov ↗
← prev
page 55 of 161
next →
$AMGN385.16-0.64%
$SNN30.25+5.29%
$JAZZ252.38-2.32%
$NRXP
$ONC316.01-1.88%
$ABBV250.94-2.51%
$JNJ258.06+0.88%
$CCCC
$SNN30.25+5.29%